NeoGenomics, Inc. Noncash or Part Noncash Acquisition, Intangible Assets Acquired
NeoGenomics, Inc. (NEO) reported Noncash or Part Noncash Acquisition, Intangible Assets Acquired of $0 for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 · last filed 2018-11-06
- NeoGenomics, Inc. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2012-12-31 was $0.00.
- NeoGenomics, Inc. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2012-09-30 was $0.00.
- NeoGenomics, Inc. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2012-06-30 was $0.00.
- NeoGenomics, Inc. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2012-03-31 was $1.95M.
- NeoGenomics, Inc. noncash or part noncash acquisition, intangible assets acquired for fiscal 2012 was $1.95M.
| Period end | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 10-Q · filed 2018-11-06 | |||
| 2017-09-30 | $4.47M 10-Q · filed 2018-11-06 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $0.00 derived: sum of 2 quarters · filed 2015-03-03 | $0.00 derived: sum of 3 quarters · filed 2015-03-03 | $1.95M 10-K · filed 2015-03-03 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $0.00 derived: sum of 2 quarters · filed 2013-10-30 | $1.95M 10-Q · filed 2013-10-30 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $1.95M 10-Q · filed 2013-08-02 | ||
| 2012-03-31 | $1.95M 10-Q · filed 2013-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |